Genomics research and diagnostics company MedGenome said today that it closed a $30 million Series C round led by Sequoia India and Sofina. Zodius Capital, the co-founder & former CEO of Infosys, Kris Gopalakrishnan, and former Cognizant CEO Lakshmi Narayanan also participated in the round.
The Foster City, Calif.-based company said it plans to use the funds to advance its biomarker discovery programs and continue development of its OncoPept cancer immunotherapy biomarker solutions.
Get the full story at our sister site, Drug Delivery Business News.
The post MedGenome raises $30m for biomarker discovery program appeared first on MassDevice.